Exome Sequencing Identifies a Significant Variant in Methionyl-Trna Synthetase (MARS) in a Family with Late-Onset CMT2.

Michael Gonzalez,Heather McLaughlin,Henry Houlden,Min Guo,Liu Yo-Tsen,Marios Hadjivassilious,Fiorella Speziani,Xiang-Lei Yang,Anthony Antonellis,Mary M. Reilly,Stephan Zuechner
DOI: https://doi.org/10.1136/jnnp-2013-305049
2013-01-01
Journal of Neurology Neurosurgery & Psychiatry
Abstract:Charcot-Marie-Tooth (CMT) disease is a genetically heterogeneous condition with >50 genes now being identified. Thanks to new technological developments, namely, exome sequencing, the ability to identify additional rare genes in CMT has been drastically improved. Here we present data suggesting that MARS is a very rare novel cause of late-onset CMT2. This is supported by strong functional and evolutionary evidence, yet the absence of additional unrelated cases warrant future studies to substantiate this conclusion.
What problem does this paper attempt to address?